Menu

Prevention &
Epidemiology

Read more

Microbicides

Read more

Vaccine &
Pathogenesis

Read more

HIV & TB
Treatment

Read more

Centre for the AIDS Programme of Research in South Africa

CAPRISA was created in 2001 and formally established in 2002 under the NIH-funded Comprehensive International Program of Research on AIDS (CIPRA) by five partner institutions; University of KwaZulu-Natal, University of Cape Town, University of Western Cape, National Institute for Communicable Diseases, and Columbia University in New York. CAPRISA is a designated UNAIDS Collaborating Centre for HIV Prevention Research. The main goal of CAPRISA is to undertake globally relevant and locally responsive research that contributes to understanding HIV pathogenesis, prevention and epidemiology as well as the links between tuberculosis and AIDS care.

Latest News

  • AIDS Researcher awarded prestigious African Union Science Prize

    SOUTH AFRICA, Durban – World-renowned South African AIDS researcher, Professor Salim S. Abdool Karim was awarded the most prestigious prize for science in Africa, the $100,000 (R1.1million) Kwame Nkrumah Scientific Award presented by the Chairperson of the African Union Commission Robert Mugabe
    Read more →

  • CAPRISA Participates in DREAMS Workshop

    Professor Quarraisha Abdool Karim, Associate Scientific Director at CAPRISA, delivered a presentation titled: Why now? PreEPping girls for an HIV-free future, at the launch of the DREAMS project, a $210million partnership funded by the Nike Foundation, Gates Foundation and PEPFAR to prevent HIV infection in adolescent girls and young women ages 15-24 held in Johannesburg on January 26, 2015.
    Read more →

  • Harvard Scientists Visit

    On Tuesday, January 20th a delegation from Harvard University delivered a seminar discussing “Novel technologies for understanding the human immune response and in vaccine development.”
    Read more →

  • Risk factors for HIV acquisition in high risk women in a generalised epidemic

    South Africa continues to experience one of the largest HIV epidemics in the world, with women bearing a disproportionate burden of HIV infection. Factors associated with HIV risk are incompletely elucidated in this setting. This study by Naicker et al published in the journal AIDS and Bahavior explored demographic, clinical and behavioural characteristics associated with HIV acquisition among 245 high risk women enrolled in the CAPRISA 002 cohort study.
    Read more →

  • NIH funds new Study

    A grant to fund a study on “Integrin a4b7 as a predictor of HIV acquisition and pathogenesis.” was awarded by the National Institutes of Health (NIH) to Dr Lyle Mckinnon (PI) who is a Research Scientist at CAPRISA and Professor Aftab Ansari (co-PI) from Emory in Atlanta, USA. Other collaborators include Dr Jim Arthos from the NIH and Professor Lynn Morris from National Institute of Communicable Diseases.
    Read more →

  • Centres of Excellence exchange ideas

    Professor Salim Abdool Karim led a senior CAPRISA delegation, to visit the Forestry and Agricultural Biotechnology Institute (FABI) at the University of Pretoria. The purpose of the visit was to establish what the two centres could learn from one another and to get a better sense of how the research centres promoted excellence.
    Read more →

Partner Institutions